Vaccination against SARS-COV-2 infection in IBD patients: should we prioritize an additional booster injection? (ECCO 2022)

Maladies infectieusesGastro-entérologieVaccinations

15/03 - Currently, little to no data is available regarding safety and efficacy of SARS-COV-2 vaccination in Inflammatory Bowel Disease (IBD) patients, which may present differences between subgroups, as these patients may exhibit impaired innate and adaptive immune system responses. Lower immunological response could, in this specific population, require an additional booster injection.